Literature DB >> 21215384

Interactive effects of DAOA (G72) and catechol-O-methyltransferase on neurophysiology in prefrontal cortex.

Devon C Nixon1, Morgan J Prust, Fabio Sambataro, Hao-Yang Tan, Venkata S Mattay, Daniel R Weinberger, Joseph H Callicott.   

Abstract

BACKGROUND: Accumulating evidence indicates that genetic polymorphisms of D-amino acid oxidase activator (DAOA) (M24; rs1421292; T-allele) and catechol-O-methyltransferase (COMT) (Val¹⁵⁸Met; rs4680) likely enhance susceptibility to schizophrenia. Previously, clinical association between DAOA M24 (T-allele) and a functionally inefficient 3-marker COMT haplotype (that included COMT Val¹⁵⁸Met) uncovered epistatic effects on risk for schizophrenia. Therefore, we projected that healthy control subjects with risk genotypes for both DAOA M24 (T/T) and COMT Val¹⁵⁸Met (Val/Val) would produce prefrontal inefficiency, a critical physiological marker of the dorsolateral prefrontal cortex (DLPFC) in schizophrenic patients influenced by both familial and heritable factors.
METHODS: With 3T blood oxygen level dependent functional magnetic resonance imaging data, we analyzed in SPM5 the proposed interaction of DAOA and COMT in 82 healthy volunteers performing an N-back executive working memory paradigm (2-back > 0-back).
RESULTS: As predicted, we detected a functional gene x gene interaction between DAOA and COMT in the DLPFC.
CONCLUSIONS: The neuroimaging findings here of inefficient information processing in the prefrontal cortex seem to echo prior statistical epistasis between risk alleles for DAOA and COMT, albeit within a small sample. These in vivo results suggest that deleterious genotypes for DAOA and COMT might contribute to the pathophysiology of schizophrenia, perhaps through combined glutamatergic and dopaminergic dysregulation.
Copyright © 2011 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21215384     DOI: 10.1016/j.biopsych.2010.10.031

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  15 in total

1.  Effects of neuregulin 3 genotype on human prefrontal cortex physiology.

Authors:  Heike Tost; Joseph H Callicott; Roberta Rasetti; Radhakrishna Vakkalanka; Venkata S Mattay; Daniel R Weinberger; Amanda J Law
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

2.  Genome-wide association study of working memory brain activation.

Authors:  Gabriëlla A M Blokland; Angus K Wallace; Narelle K Hansell; Paul M Thompson; Ian B Hickie; Grant W Montgomery; Nicholas G Martin; Katie L McMahon; Greig I de Zubicaray; Margaret J Wright
Journal:  Int J Psychophysiol       Date:  2016-09-23       Impact factor: 2.997

3.  Animal Models of Psychosis: Current State and Future Directions.

Authors:  Alexandra D Forrest; Carlos A Coto; Steven J Siegel
Journal:  Curr Behav Neurosci Rep       Date:  2014-06-01

4.  Genetic variation in GAD1 is associated with cortical thickness in the parahippocampal gyrus.

Authors:  Stefan Brauns; Randy L Gollub; Esther Walton; Johanna Hass; Michael N Smolka; Tonya White; Thomas H Wassink; Vince D Calhoun; Stefan Ehrlich
Journal:  J Psychiatr Res       Date:  2013-04-06       Impact factor: 4.791

5.  Interaction between effects of genes coding for dopamine and glutamate transmission on striatal and parahippocampal function.

Authors:  Andreina Pauli; Diana P Prata; Andrea Mechelli; Marco Picchioni; Cynthia H Y Fu; Christopher A Chaddock; Fergus Kane; Sridevi Kalidindi; Colm McDonald; Eugenia Kravariti; Timothea Toulopoulou; Elvira Bramon; Muriel Walshe; Natascha Ehlert; Anna Georgiades; Robin Murray; David A Collier; Philip McGuire
Journal:  Hum Brain Mapp       Date:  2012-03-22       Impact factor: 5.038

6.  Schizophrenia miR-137 locus risk genotype is associated with dorsolateral prefrontal cortex hyperactivation.

Authors:  Theo G M van Erp; Ilaria Guella; Marquis P Vawter; Jessica Turner; Gregory G Brown; Gregory McCarthy; Douglas N Greve; Gary H Glover; Vince D Calhoun; Kelvin O Lim; Juan R Bustillo; Aysenil Belger; Judith M Ford; Daniel H Mathalon; Michele Diaz; Adrian Preda; Dana Nguyen; Fabio Macciardi; Steven G Potkin
Journal:  Biol Psychiatry       Date:  2013-08-01       Impact factor: 13.382

7.  Sex differences in COMT polymorphism effects on prefrontal inhibitory control in adolescence.

Authors:  Thomas P White; Eva Loth; Katya Rubia; Lydia Krabbendam; Robert Whelan; Tobias Banaschewski; Gareth J Barker; Arun L W Bokde; Christian Büchel; Patricia Conrod; Mira Fauth-Bühler; Herta Flor; Vincent Frouin; Jürgen Gallinat; Hugh Garavan; Penny Gowland; Andreas Heinz; Bernd Ittermann; Claire Lawrence; Karl Mann; Marie-Laure Paillère; Frauke Nees; Tomas Paus; Zdenka Pausova; Marcella Rietschel; Trevor Robbins; Michael N Smolka; Sukhwinder S Shergill; Gunter Schumann
Journal:  Neuropsychopharmacology       Date:  2014-05-13       Impact factor: 7.853

8.  Dopamine transporter DAT and receptor DRD2 variants affect risk of lethal cocaine abuse: a gene-gene-environment interaction.

Authors:  D Sullivan; J K Pinsonneault; A C Papp; H Zhu; S Lemeshow; D C Mash; W Sadee
Journal:  Transl Psychiatry       Date:  2013-01-22       Impact factor: 6.222

9.  Antipsychotic medications and cognitive functioning in bipolar disorder: moderating effects of COMT Val108/158 Met genotype.

Authors:  Baer Arts; Claudia J P Simons; Marjan Drukker; Jim van Os
Journal:  BMC Psychiatry       Date:  2013-02-19       Impact factor: 3.630

10.  The influence of polygenic risk for bipolar disorder on neural activation assessed using fMRI.

Authors:  H C Whalley; M Papmeyer; E Sprooten; L Romaniuk; D H Blackwood; D C Glahn; J Hall; S M Lawrie; Je Sussmann; A M McIntosh
Journal:  Transl Psychiatry       Date:  2012-07-03       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.